Lataa...
Identification and characterization of a novel agonistic anti-DR4 human monoclonal antibody
The tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its functional receptors, DR4 and DR5, have been established as promising targets for cancer treatment. Therapeutics targeting TRAIL and its receptors are not only effective in killing many types of tumors, but they also synergi...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Landes Bioscience
2010
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2958577/ https://ncbi.nlm.nih.gov/pubmed/20581445 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/mabs.2.5.12570 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|